ScholarIQanswers from OpenAlex

Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients

PaperCitations, authors & open-access status

Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients have?

ScholarIQcitation count

Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients has 472 citations in the OpenAlex counts ScholarIQ stores.

When was Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients published?

ScholarIQyear

Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients has 2008 year in the ScholarIQ index.

What is the open-access status of Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients?

ScholarIQoa status

Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients has closed oa status in the ScholarIQ index.

What is the DOI of Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients?

ScholarIQdoi

The DOI for Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients is on the source record.

What is the PMID of Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients?

ScholarIQpmid

The PMID for Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients is on the source record.

What is the OpenAlex record for Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients?

ScholarIQopenalex

The OpenAlex for Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial